Clinical Trial Update: Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients

View source ↗

Summary

This completed clinical trial provides results from a specified drug-use survey of ipragliflozin treatment in patients with Type 2 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Suglat (ipragliflozin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes | Status: COMPLETED